![](img011.GIF) |
These data from the antiplatelet Trialist’s Collaborative
Study. 45000 patients were randomized either to antiplatelet drugs or to placebo. In this
slide I show the benefits of antiplatelet therapy among patients with diabetes and without
diabetes. Among both groups there is around 20% reduction in event rate. For every 1000
patients treated (without diabetes) some 36 events are prevented and for patients with
diabetes it is 38 for every 1000 treated. There are suggestions that patients with
diabetes should use up to 300 mg of aspirin daily. |